Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/28/2905822/0/en/Ardelyx-Presents-Additional-Data-Detailing-Educational-Needs-Related-to-IBS-C-Management-Across-Healthcare-Disciplines.html
https://www.globenewswire.com/news-release/2024/05/30/2891114/0/en/Ardelyx-Inc-Reports-Employment-Inducement-Grants.html
https://www.globenewswire.com/news-release/2024/05/22/2886462/0/en/Ardelyx-to-Participate-at-the-2024-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/21/2885550/0/en/Ardelyx-Presents-Additional-Data-at-the-2024-Digestive-Disease-Week-Conference-on-IBSRELA-tenapanor-a-First-In-Class-Treatment-for-IBS-C-in-Adults.html
https://www.globenewswire.com/news-release/2024/05/16/2883372/0/en/Ardelyx-Presents-Additional-Data-at-the-NKF-2024-Spring-Clinical-Meetings-on-XPHOZAH-tenapanor.html
https://www.globenewswire.com/news-release/2024/05/14/2881843/0/en/Ardelyx-Inc-Reports-Employment-Inducement-Grants.html
https://www.globenewswire.com/news-release/2024/05/07/2876706/0/en/Ardelyx-to-Present-Additional-Data-Supporting-First-In-Class-IBSRELA-tenapanor-for-Adults-with-Irritable-Bowel-Syndrome-with-Constipation-at-the-2024-Digestive-Disease-Week-Confere.html
https://www.globenewswire.com/news-release/2024/05/02/2874659/0/en/Ardelyx-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/05/01/2873169/0/en/Ardelyx-to-Present-Additional-Data-Supporting-First-In-Class-XPHOZAH-tenapanor-for-Adults-with-Chronic-Kidney-Disease-on-Dialysis-at-the-National-Kidney-Foundation-2024-Spring-Clin.html
https://www.globenewswire.com/news-release/2024/04/18/2865353/0/en/Ardelyx-to-Report-First-Quarter-2024-Financial-Results-on-May-2-2024.html